Date Marketed In

Published on British Columbia Drug and Poison Information Centre (BC DPIC) ( http://www.dpic.org)

Home > Drug Product Listings > Eculizumab > Printer-friendly PDF

Eculizumab

Trade Name: Soliris Manufacturer/Distributor: Alexion Pharmaceticals 1-888-765-4747 www.alxn.com Classification: Humanized monoclonal antibody ATC Class: L04AA25 Status: active Notice of Compliance (yyyy/mm/dd): 2009/01/28 Date Marketed in Canada (yyyy/mm/dd): 2009/06/29 Presentation: Injectable solution 10 mg/mL; DIN 02322285 Comments: Terminal complement inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria to reduce hemolysis. Source: Letter from company Keywords: eculizumab Access: public Back to: Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database Status: ?

Search Terms:

Apply A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4) Date Marketed in Common Trade Generic Name Classification Canada Name(s) (yyyy/mm/dd) Non-steroidal aromatase inhibitor; inhibitor of Letrozole Femara estrogen biosynthesis; antitumor agent Tramadol Tridural Analgesic Pregabalin Lyrica Analgesic Polyethylene glycol Pegalax Laxative 3350 Heparin Sodium Hepalean Heparin anticoagulant Estropipate Ogen Apo-digoxin; pms- Digoxin Digoxin; Lanoxin Cilazapril Inhibace ACE inhibitor Panoxyl Clear Salicylic acid + Acne Cleansing Triclosan Gel Risedronate sodium Actonel Bisphosphonate Risedronate + Actonel APC Calcium carbonate Lenalidomide Revlimid Antineoplastic agent Midodrine Amantine Alpha adrenergic agonist Norgestrel + ethinyl Ovral Oral contraceptive estradiol Ethinyl estradiol + Ovral Oral contraceptive norgestrel Propoxyphene Darvon-N; 642 Narcotic Endothelin receptor Sitaxsentan Thelin antagonist Lithium, sustained Lithmax Antimanic agents release Aluminum chloride Hydrosal gel Antiperspirant hexahydrate Probenecid Benuryl Uricosuric agent Digoxin Immune Fab Digibind Antidote (Ovine) Date Marketed in Common Trade Generic Name Classification Canada Name(s) (yyyy/mm/dd) Pontocaine (spinal Tetracaine Local anesthetic anesthesia) ALK Tyrosine Kinase Crizotinib Xalkori Inhibitor Oxybutynin Uromax Urinary Antispasmodic Dilaudid injection; Hydromorphone Dilaudid HP Narcotic injection Rocaltrol oral Calcitriol Vitamin D analogue solution Miacalcin NS, Calcitonin salmon Sandoz Calcitonin Bone metabolism nasal spray NS, Apo- regulator Calcitonin NS ASA + Meprobamate 282 MEP Narcotic analgesic + Codeine + Caffeine Isopto Homatropine Mydriatic agent Homatropine Hydrocodone resin Tussionex tablets Narcotic with phenyltoloxamine Metronidazole with Flagystatin vaginal nystatin vaginal cream cream Leukotriene modifier for Zafirlukast Accolate asthma Clofedanol Ulone Antitussive Selective progesterone Ulipristal Fibristal receptor modulator (SERM) Protein kinase inibitor Tepotinib Tepmetko (antineoplastic agent) Entrectinib Rozlytrek Antineoplastic agent 1 2 3 4 5 6 7 8 9 ? next ? last »

All material found on the BC Drug and Poison Information Centre (DPIC) website is provided for informational purposes only. It is not meant to replace the expert advice of a healthcare professional such as a physician, pharmacist, nurse or qualified poison specialist. Use of this site is governed and restricted by specific terms of use. Please review the full terms and conditions below prior to using the DPIC website. In the event of a poisoning emergency, call your local poison control centre immediately. Portions of this web site are intended for healthcare professionals. Interpretation and application of information may require more detailed explanation than contained herein, particularly regarding any clinical information that is found in or linked to this site. Patients are advised to consult their health care provider regarding diagnosis and treatment, and for assistance in interpreting these materials and applying them in individual cases. Terms and Conditions

Source URL (retrieved on 2021-10-02 07:34): http://www.dpic.org/druglisting/eculizumab